anmelden
Sanofi Aktie
75,65
EUR
-0,18
EUR
-0,24
%
70,84
CHF
+0,24
CHF
+0,34
%
Sanofi jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 89,86 Mrd. EUR
KGV 19,40 Div. Rendite 4,98%WKN 920657
ISIN FR0000120578
Symbol SNYNF
AI Analyse
Werbung
Sanofi Aktie Analyse
| 14.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 09.03.22 | Sanofi Equal Weight | Barclays Capital | |
| 08.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 08.03.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 07.03.22 | Sanofi Buy | UBS AG | |
| 21.02.22 | Sanofi Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.02.22 | Sanofi Buy | UBS AG | |
| 09.02.22 | Sanofi Sell | Deutsche Bank AG | |
|
Werbung
|
|||
| 08.02.22 | Sanofi Equal Weight | Barclays Capital | |
| 07.02.22 | Sanofi Outperform | Credit Suisse Group | |
| 04.02.22 | Sanofi Buy | UBS AG | |
| 04.02.22 | Sanofi Outperform | Bernstein Research | |
| 04.02.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 04.02.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.02.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 31.01.22 | Sanofi Equal Weight | Barclays Capital | |
| 28.01.22 | Sanofi Sell | Deutsche Bank AG | |
| 27.01.22 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 26.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 13.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 06.01.22 | Sanofi Buy | UBS AG | |
| 05.01.22 | Sanofi Outperform | Credit Suisse Group | |
| 04.01.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 04.01.22 | Sanofi Outperform | Bernstein Research | |
| 15.12.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 10.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 07.12.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 03.12.21 | Sanofi Buy | UBS AG | |
| 03.12.21 | Sanofi Sell | Deutsche Bank AG | |
| 02.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 02.12.21 | Sanofi Buy | Kepler Cheuvreux | |
| 02.12.21 | Sanofi Outperform | Credit Suisse Group | |
| 02.12.21 | Sanofi Buy | UBS AG | |
| 02.12.21 | Sanofi Equal Weight | Barclays Capital | |
| 01.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 29.11.21 | Sanofi Buy | UBS AG | |
| 24.11.21 | Sanofi Buy | UBS AG | |
| 11.11.21 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 29.10.21 | Sanofi Sell | Deutsche Bank AG | |
| 29.10.21 | Sanofi Buy | UBS AG | |
| 29.10.21 | Sanofi Outperform | Credit Suisse Group | |
| 29.10.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.10.21 | Sanofi Buy | Goldman Sachs Group Inc. | |
| 28.10.21 | Sanofi Overweight | Morgan Stanley | |
| 28.10.21 | Sanofi Outperform | Bernstein Research | |
| 28.10.21 | Sanofi Buy | Kepler Cheuvreux | |
| 28.10.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.10.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 26.10.21 | Sanofi Sell | Deutsche Bank AG | |
| 22.10.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
Werbung
Werbung
